China NMPA Drug Inspection - Beijing Tongrentang (Bozhou) Pharmaceutical Co., Ltd. - Eclipta prostrata

China NMPA drug inspection for Beijing Tongrentang (Bozhou) Pharmaceutical Co., Ltd. published November 22, 2019. Drug: Eclipta prostrata. The Chongqing Municipal Drug Administration, in an announcement dated November 22, 2019, reported significant quality co

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Beijing Tongrentang (Bozhou) Pharmaceutical Co., Ltd.

Inspection Date

Unknown Date

Product Type

ID: 28e2475e-af93-4172-accc-2d3722b1f451

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox